Paragraph 15 Other goodsF1
Chemical agents, including tear gas formulation containing 1 per cent. or less of orthochlorobenzalmalononitrile (CS), or 1 per cent. or less of chloroacetophenone (CN), except in individual containers with a net weight of 20 grams or less; liquid pepper except when packaged in individual containers with a net weight of 3 ounces (85.05 grams) or less; smoke bombs; non-irritant smoke flares, canisters, grenades and charges; and other pyrotechnic articles having dual military and commercial use, and specially designed components thereof.
Other irritating chemical substances, and mixtures thereof containing at least 0.3 % by weight of the active substance, as follows, except where the material is incorporated in a medical product—
| Commodity Code | Description |
|---|---|
| 2934 9990 | Dibenzo[b,f][1,4]oxazepine (CR) (CAS 257-07-8) |
| 2939 7990 | 8-Methyl-N-vanillyl-trans-6-nonenamide (capsaicin) (CAS 404-86-4) |
| 2939 7990 | 8-Methyl-N-vanillylnonamide (dihydrocapsaicin) (CAS 19408-84-5) |
| 2939 7990 | N-Vanillyl-9-methyldec-7-(E)-enamide (homocapsaicin) (CAS 58493-48-4) |
| 2939 7990 | N-Vanillyl-9-methyldecanamide (homodihydrocapsaicin) (CAS 20279-06-5) |
| 2939 7990 | N-Vanillyl-7-methyloctanamide (nordihydrocapsaicin) (CAS 28789-35-7) |
| 2934 9990 | 4-Nonanolylmorpholine (MPA) (CAS 5299-64-9) |
| 2924 2970 | Cis-4-acetylaminodicyclohexylmethane (CAS 37794-87-9) |
| F4. . . | . . . |
| . . . | . . . |
| F52926 9070 | Malononitrile (CAS 109-77-3) |
| 2922 29 | o-Aminophenol (CAS 95-55-6) |
| . . . | . . . |
| 2915 9070 | Chloroacetyl Chloride (CAS 79-04-9) |
| 2914 39 | Acetophenone (CAS 98-86-2) |
| 2913 | 2-Chlorobenzaldehyde (CAS 89-98-5) |
| 2906 29 | 2-Chlorobenzyl Alcohol (CAS 17849-38-6) |
| 2903 9980 | Benzene, 1-chloro-2-(dimethoxymethyl) (CAS 70380-66-4) |
| 2903 13 | Chloroform (CAS 67-66-3) |
Note: For the purposes of paragraph (2) which precedes this table, “medical product” means— (1) a pharmaceutical formulation designed for human administration in the treatment of medical conditions, and (2) prepackaged for distribution as a clinical or medical product. | |
Annotations
Textual amendments
- F1
Sch. 3C inserted (15.7.2022) by The Russia (Sanctions) (EU Exit) (Amendment) (No. 11) Regulations 2022 (S.I. 2022/792), reg. 1(2), Sch. 3 (with reg. 13)
- F2
Sch. 3C Pt. 3 para. 15 renumbered as Sch. 3C Pt. 3 para. 15(1) (21.4.2023) by The Russia (Sanctions) (EU Exit) (Amendment) Regulations 2023 (S.I. 2023/440), regs. 1(2), 14(5)(a)
- F3
Sch. 3C Pt. 3 para. 15(2) inserted (21.4.2023) by The Russia (Sanctions) (EU Exit) (Amendment) Regulations 2023 (S.I. 2023/440), regs. 1(2), 14(5)(b)
- F4
Words in Sch. 3C Pt. 3 omitted (20.5.2026) by virtue of The Russia (Sanctions) (EU Exit) (Amendment) Regulations 2026 (S.I. 2026/543), regs. 1(2), 29(8), Sch. 4 para. 2
- F5
Words in Sch. 3C Pt. 3 para. 15(2) table inserted (24.4.2025) by The Russia (Sanctions) (EU Exit) (Amendment) Regulations 2025 (S.I. 2025/504), regs. 1(2), 16(10) (with reg. 17)
Notes on the whole SI
Textual amendments
- F1
Regulations extended (British overseas territories) (with modifications) (31.12.2020 immediately after both S.I. 2020/590 and S.I. 2020/951 have come into force) by The Russia (Sanctions) (Overseas Territories) Order 2020 (S.I. 2020/1571), arts. 1(1), 2, Schs. 1, 2 (as amended: (11.3.2021) by S.I. 2021/288, arts. 1(1), 2(2); (14.4.2022) by S.I. 2022/453, arts. 1(1), 3-38; (20.7.2022) by S.I. 2022/843, arts. 1(1), 3; (10.11.2022) by S.I. 2022/1167, arts. 1(1), 3-17; (15.12.2022) by S.I. 2022/1338, arts. 1(1), 3-10; (9.3.2023) by S.I. 2023/291, arts. 1(1), 3-9; (20.7.2023) by S.I. 2023/846, arts. 1(1), 3, 5-22; (30.9.2023) by S.I. 2023/846, arts. 1(2), 4; (14.3.2024) by S.I. 2024/370, arts. 1, 3-13; (3.10.2024) by S.I. 2024/987, arts. 1(1), 3-6; and (11.12.2025) by S.I. 2025/1307, art. 1(1), Sch. 15)
Notes on Schedule 3C
Textual amendments
- F2
Sch. 3C heading substituted (29.10.2022) by The Russia (Sanctions) (EU Exit) (Amendment) (No. 15) Regulations 2022 (S.I. 2022/1110), reg. 1(2)(b), Sch. 3 para. 8